カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の眼科用非ステロイド性抗炎症薬市場2023年：企業・地域・タイプ・用途別分析

■ 英語タイトル：Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23SM7953）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23SM7953
■ 発行日：2023年9月
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：111
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥522,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥783,000見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,044,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の眼科用非ステロイド性抗炎症薬市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

GlobalInfoResearchの最新の調査によると、世界の眼科用非ステロイド性抗炎症薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の眼科用非ステロイド性抗炎症薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 眼科用非ステロイド性抗炎症薬の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

眼科用非ステロイド性抗炎症薬市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・プラノプロフェン点眼液、ジクロフェナクナトリウム点眼液、ブロムフェナクナトリウム点眼液、その他

用途別セグメント
・病院、診療所、その他

主要な市場プレーヤー
・AbbVie、Bausch Health、Bayer、Dossa Pharmaceuticals、GlaxoSmithKline、Janssen Pharmaceuticals、Novartis、Pfizer、Sun Pharmaceutical Industries、Senju Pharmaceutical、Sichuan Heyi Pharmaceutical、Shandong Haishan Pharmaceutical、Guangdong Zhongsheng Pharmaceutical、Hangzhou Minsheng Pharmaceutical、Cisen Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、眼科用非ステロイド性抗炎症薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な眼科用非ステロイド性抗炎症薬メーカーの企業概要、2019年～2022年までの眼科用非ステロイド性抗炎症薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な眼科用非ステロイド性抗炎症薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別眼科用非ステロイド性抗炎症薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの眼科用非ステロイド性抗炎症薬のタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での眼科用非ステロイド性抗炎症薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および眼科用非ステロイド性抗炎症薬の産業チェーンを掲載しています。
・第14、15章では、眼科用非ステロイド性抗炎症薬の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 眼科用非ステロイド性抗炎症薬の概要
– タイプ別分析（2018年vs2022年vs2029年）：プラノプロフェン点眼液、ジクロフェナクナトリウム点眼液、ブロムフェナクナトリウム点眼液、その他
– 用途別分析（2018年vs2022年vs2029年）：病院、診療所、その他
– 世界の眼科用非ステロイド性抗炎症薬市場規模・予測
– 世界の眼科用非ステロイド性抗炎症薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– AbbVie、Bausch Health、Bayer、Dossa Pharmaceuticals、GlaxoSmithKline、Janssen Pharmaceuticals、Novartis、Pfizer、Sun Pharmaceutical Industries、Senju Pharmaceutical、Sichuan Heyi Pharmaceutical、Shandong Haishan Pharmaceutical、Guangdong Zhongsheng Pharmaceutical、Hangzhou Minsheng Pharmaceutical、Cisen Pharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：プラノプロフェン点眼液、ジクロフェナクナトリウム点眼液、ブロムフェナクナトリウム点眼液、その他
・用途別分析2018年-2029年：病院、診療所、その他
・眼科用非ステロイド性抗炎症薬の北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・眼科用非ステロイド性抗炎症薬のヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・眼科用非ステロイド性抗炎症薬のアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・眼科用非ステロイド性抗炎症薬の南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・眼科用非ステロイド性抗炎症薬の中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Non-steroidal Anti-inflammatory Drugs for Ophthalmology
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Pranoprofen Eye Drops
1.3.3 Diclofenac Sodium Eye Drops
1.3.4 Bromfenac Sodium Eye Drops
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Size & Forecast
1.5.1 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity (2018-2029)
1.5.3 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Average Price (2018-2029)
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.1.4 AbbVie Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AbbVie Recent Developments/Updates
2.2 Bausch Health
2.2.1 Bausch Health Details
2.2.2 Bausch Health Major Business
2.2.3 Bausch Health Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.2.4 Bausch Health Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bausch Health Recent Developments/Updates
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.3.4 Bayer Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bayer Recent Developments/Updates
2.4 Dossa Pharmaceuticals
2.4.1 Dossa Pharmaceuticals Details
2.4.2 Dossa Pharmaceuticals Major Business
2.4.3 Dossa Pharmaceuticals Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.4.4 Dossa Pharmaceuticals Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Dossa Pharmaceuticals Recent Developments/Updates
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.5.4 GlaxoSmithKline Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 GlaxoSmithKline Recent Developments/Updates
2.6 Janssen Pharmaceuticals
2.6.1 Janssen Pharmaceuticals Details
2.6.2 Janssen Pharmaceuticals Major Business
2.6.3 Janssen Pharmaceuticals Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.6.4 Janssen Pharmaceuticals Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Janssen Pharmaceuticals Recent Developments/Updates
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.7.4 Novartis Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Novartis Recent Developments/Updates
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.8.4 Pfizer Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Pfizer Recent Developments/Updates
2.9 Sun Pharmaceutical Industries
2.9.1 Sun Pharmaceutical Industries Details
2.9.2 Sun Pharmaceutical Industries Major Business
2.9.3 Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.9.4 Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sun Pharmaceutical Industries Recent Developments/Updates
2.10 Senju Pharmaceutical
2.10.1 Senju Pharmaceutical Details
2.10.2 Senju Pharmaceutical Major Business
2.10.3 Senju Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.10.4 Senju Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Senju Pharmaceutical Recent Developments/Updates
2.11 Sichuan Heyi Pharmaceutical
2.11.1 Sichuan Heyi Pharmaceutical Details
2.11.2 Sichuan Heyi Pharmaceutical Major Business
2.11.3 Sichuan Heyi Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.11.4 Sichuan Heyi Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Sichuan Heyi Pharmaceutical Recent Developments/Updates
2.12 Shandong Haishan Pharmaceutical
2.12.1 Shandong Haishan Pharmaceutical Details
2.12.2 Shandong Haishan Pharmaceutical Major Business
2.12.3 Shandong Haishan Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.12.4 Shandong Haishan Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Shandong Haishan Pharmaceutical Recent Developments/Updates
2.13 Guangdong Zhongsheng Pharmaceutical
2.13.1 Guangdong Zhongsheng Pharmaceutical Details
2.13.2 Guangdong Zhongsheng Pharmaceutical Major Business
2.13.3 Guangdong Zhongsheng Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.13.4 Guangdong Zhongsheng Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Guangdong Zhongsheng Pharmaceutical Recent Developments/Updates
2.14 Hangzhou Minsheng Pharmaceutical
2.14.1 Hangzhou Minsheng Pharmaceutical Details
2.14.2 Hangzhou Minsheng Pharmaceutical Major Business
2.14.3 Hangzhou Minsheng Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.14.4 Hangzhou Minsheng Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Hangzhou Minsheng Pharmaceutical Recent Developments/Updates
2.15 Cisen Pharmaceutical
2.15.1 Cisen Pharmaceutical Details
2.15.2 Cisen Pharmaceutical Major Business
2.15.3 Cisen Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
2.15.4 Cisen Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Cisen Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Non-steroidal Anti-inflammatory Drugs for Ophthalmology by Manufacturer
3.1 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Manufacturer (2018-2023)
3.2 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Revenue by Manufacturer (2018-2023)
3.3 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Non-steroidal Anti-inflammatory Drugs for Ophthalmology by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Manufacturer Market Share in 2022
3.4.2 Top 6 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Manufacturer Market Share in 2022
3.5 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market: Overall Company Footprint Analysis
3.5.1 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market: Region Footprint
3.5.2 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market: Company Product Type Footprint
3.5.3 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Size by Region
4.1.1 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Region (2018-2029)
4.1.2 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Region (2018-2029)
4.1.3 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Average Price by Region (2018-2029)
4.2 North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value (2018-2029)
4.3 Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value (2018-2029)
4.4 Asia-Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value (2018-2029)
4.5 South America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value (2018-2029)
4.6 Middle East and Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Type (2018-2029)
5.2 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Type (2018-2029)
5.3 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Application (2018-2029)
6.2 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Application (2018-2029)
6.3 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Average Price by Application (2018-2029)
7 North America
7.1 North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Type (2018-2029)
7.2 North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Application (2018-2029)
7.3 North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Size by Country
7.3.1 North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Country (2018-2029)
7.3.2 North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Type (2018-2029)
8.2 Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Application (2018-2029)
8.3 Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Size by Country
8.3.1 Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Country (2018-2029)
8.3.2 Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Size by Region
9.3.1 Asia-Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Type (2018-2029)
10.2 South America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Application (2018-2029)
10.3 South America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Size by Country
10.3.1 South America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Country (2018-2029)
10.3.2 South America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Size by Country
11.3.1 Middle East & Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Drivers
12.2 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Restraints
12.3 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Non-steroidal Anti-inflammatory Drugs for Ophthalmology and Key Manufacturers
13.2 Manufacturing Costs Percentage of Non-steroidal Anti-inflammatory Drugs for Ophthalmology
13.3 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Production Process
13.4 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Typical Distributors
14.3 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. AbbVie Basic Information, Manufacturing Base and Competitors
Table 4. AbbVie Major Business
Table 5. AbbVie Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
Table 6. AbbVie Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. AbbVie Recent Developments/Updates
Table 8. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 9. Bausch Health Major Business
Table 10. Bausch Health Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
Table 11. Bausch Health Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Bausch Health Recent Developments/Updates
Table 13. Bayer Basic Information, Manufacturing Base and Competitors
Table 14. Bayer Major Business
Table 15. Bayer Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
Table 16. Bayer Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Bayer Recent Developments/Updates
Table 18. Dossa Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. Dossa Pharmaceuticals Major Business
Table 20. Dossa Pharmaceuticals Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
Table 21. Dossa Pharmaceuticals Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Dossa Pharmaceuticals Recent Developments/Updates
Table 23. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 24. GlaxoSmithKline Major Business
Table 25. GlaxoSmithKline Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
Table 26. GlaxoSmithKline Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. GlaxoSmithKline Recent Developments/Updates
Table 28. Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Janssen Pharmaceuticals Major Business
Table 30. Janssen Pharmaceuticals Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
Table 31. Janssen Pharmaceuticals Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Janssen Pharmaceuticals Recent Developments/Updates
Table 33. Novartis Basic Information, Manufacturing Base and Competitors
Table 34. Novartis Major Business
Table 35. Novartis Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
Table 36. Novartis Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Novartis Recent Developments/Updates
Table 38. Pfizer Basic Information, Manufacturing Base and Competitors
Table 39. Pfizer Major Business
Table 40. Pfizer Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
Table 41. Pfizer Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Pfizer Recent Developments/Updates
Table 43. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 44. Sun Pharmaceutical Industries Major Business
Table 45. Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
Table 46. Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Sun Pharmaceutical Industries Recent Developments/Updates
Table 48. Senju Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 49. Senju Pharmaceutical Major Business
Table 50. Senju Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
Table 51. Senju Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Senju Pharmaceutical Recent Developments/Updates
Table 53. Sichuan Heyi Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Sichuan Heyi Pharmaceutical Major Business
Table 55. Sichuan Heyi Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
Table 56. Sichuan Heyi Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Sichuan Heyi Pharmaceutical Recent Developments/Updates
Table 58. Shandong Haishan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 59. Shandong Haishan Pharmaceutical Major Business
Table 60. Shandong Haishan Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
Table 61. Shandong Haishan Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Shandong Haishan Pharmaceutical Recent Developments/Updates
Table 63. Guangdong Zhongsheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. Guangdong Zhongsheng Pharmaceutical Major Business
Table 65. Guangdong Zhongsheng Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
Table 66. Guangdong Zhongsheng Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Guangdong Zhongsheng Pharmaceutical Recent Developments/Updates
Table 68. Hangzhou Minsheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 69. Hangzhou Minsheng Pharmaceutical Major Business
Table 70. Hangzhou Minsheng Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
Table 71. Hangzhou Minsheng Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Hangzhou Minsheng Pharmaceutical Recent Developments/Updates
Table 73. Cisen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Cisen Pharmaceutical Major Business
Table 75. Cisen Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product and Services
Table 76. Cisen Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Cisen Pharmaceutical Recent Developments/Updates
Table 78. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Non-steroidal Anti-inflammatory Drugs for Ophthalmology, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Non-steroidal Anti-inflammatory Drugs for Ophthalmology Production Site of Key Manufacturer
Table 83. Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market: Company Product Type Footprint
Table 84. Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market: Company Product Application Footprint
Table 85. Non-steroidal Anti-inflammatory Drugs for Ophthalmology New Market Entrants and Barriers to Market Entry
Table 86. Non-steroidal Anti-inflammatory Drugs for Ophthalmology Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Non-steroidal Anti-inflammatory Drugs for Ophthalmology Raw Material
Table 146. Key Manufacturers of Non-steroidal Anti-inflammatory Drugs for Ophthalmology Raw Materials
Table 147. Non-steroidal Anti-inflammatory Drugs for Ophthalmology Typical Distributors
Table 148. Non-steroidal Anti-inflammatory Drugs for Ophthalmology Typical Customers
List of Figures
Figure 1. Non-steroidal Anti-inflammatory Drugs for Ophthalmology Picture
Figure 2. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value Market Share by Type in 2022
Figure 4. Pranoprofen Eye Drops Examples
Figure 5. Diclofenac Sodium Eye Drops Examples
Figure 6. Bromfenac Sodium Eye Drops Examples
Figure 7. Other Examples
Figure 8. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value Market Share by Application in 2022
Figure 10. Hospital Examples
Figure 11. Clinic Examples
Figure 12. Other Examples
Figure 13. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Non-steroidal Anti-inflammatory Drugs for Ophthalmology by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value Market Share by Region (2018-2029)
Figure 55. China Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Drivers
Figure 76. Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Restraints
Figure 77. Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Non-steroidal Anti-inflammatory Drugs for Ophthalmology in 2022
Figure 80. Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs for Ophthalmology
Figure 81. Non-steroidal Anti-inflammatory Drugs for Ophthalmology Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 非ステロイド性抗炎症薬（NSAID）のグローバル市場展望 2023年-2029年：サリチル酸塩、プロピオン酸誘導体、酢酸誘導体、エノール酸（オキシカム）誘導体、アントラニル酸誘導体（フェナム酸）、選択的COX-2阻害剤（コキシブ）、サルファ薬
  • 世界の頸椎症治療薬市場2023年：企業・地域・タイプ・用途別分析
  • 世界のNSAID点眼薬市場2023年：企業・地域・タイプ・用途別分析
  • 世界の神経芽腫に対する化学療法薬市場2023年：企業・地域・タイプ・用途別分析
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23SM7953 )"世界の眼科用非ステロイド性抗炎症薬市場2023年：企業・地域・タイプ・用途別分析" (英文：Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。